In addition, metformin, through the AMPK-CEBPβ pathway, targets and inhibits the expression of the HCC cell surface membrane protein CD133, suggesting that metformin regulates the expression of membrane proteins and plays a cancer-suppressing role [51]. This evidence concerns the gene CEBPB and hepatocellular carcinoma.